Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma

Background: Proton beam has an excellent depth dose distribution due to its unique physical properties, and thus proton beam therapy (PBT) has been tried and showed promising outcomes in hepatocellular carcinoma (HCC). The purpose of this phase II study is to evaluate the efficacy of hypofractionate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Kim, Tae Hyun, Park, Joong-Won, Kim, Bo Hyun, Oh, Eun Sang, Youn, Sang Hee, Moon, Sung Ho, Kim, Sang Soo, Woo, Sang Myung, Koh, Young-Hwan, Lee, Woo Jin, Kim, Dae Yong
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7198869/
https://ncbi.nlm.nih.gov/pubmed/32411594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados